Insulet EBIT Margin 2010-2025 | PODD
Insulet EBIT Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBIT | EBIT Margin |
2025-03-31 | $2.20B | $0.34B | 15.50% |
2024-12-31 | $2.07B | $0.31B | 14.91% |
2024-09-30 | $1.99B | $0.31B | 15.42% |
2024-06-30 | $1.87B | $0.27B | 14.57% |
2024-03-31 | $1.78B | $0.25B | 13.97% |
2023-12-31 | $1.70B | $0.22B | 12.96% |
2023-09-30 | $1.56B | $0.14B | 8.86% |
2023-06-30 | $1.47B | $0.09B | 5.87% |
2023-03-31 | $1.37B | $0.03B | 2.05% |
2022-12-31 | $1.31B | $0.04B | 2.91% |
2022-09-30 | $1.24B | $0.06B | 5.15% |
2022-06-30 | $1.18B | $0.10B | 8.06% |
2022-03-31 | $1.14B | $0.15B | 12.96% |
2021-12-31 | $1.10B | $0.13B | 11.46% |
2021-09-30 | $1.04B | $0.07B | 6.65% |
2021-06-30 | $1.00B | $0.06B | 5.93% |
2021-03-31 | $0.96B | $0.06B | 6.37% |
2020-12-31 | $0.90B | $0.05B | 5.86% |
2020-09-30 | $0.87B | $0.08B | 9.00% |
2020-06-30 | $0.83B | $0.07B | 8.61% |
2020-03-31 | $0.78B | $0.05B | 6.57% |
2019-12-31 | $0.74B | $0.05B | 6.78% |
2019-09-30 | $0.69B | $0.05B | 6.92% |
2019-06-30 | $0.65B | $0.04B | 5.82% |
2019-03-31 | $0.60B | $0.03B | 5.67% |
2018-12-31 | $0.56B | $0.03B | 4.79% |
2018-09-30 | $0.53B | $0.01B | 1.89% |
2018-06-30 | $0.50B | $0.01B | 1.00% |
2018-03-31 | $0.49B | $0.00B | -0.41% |
2017-12-31 | $0.47B | $-0.01B | -1.51% |
2017-09-30 | $0.44B | $-0.01B | -2.28% |
2017-06-30 | $0.41B | $-0.01B | -2.43% |
2017-03-31 | $0.39B | $-0.01B | -2.06% |
2016-12-31 | $0.37B | $-0.01B | -3.00% |
2016-09-30 | $0.35B | $-0.02B | -5.76% |
2016-06-30 | $0.32B | $-0.04B | -11.46% |
2016-03-31 | $0.30B | $-0.05B | -16.84% |
2015-12-31 | $0.26B | $-0.05B | -18.56% |
2015-09-30 | $0.20B | $-0.04B | -17.95% |
2015-06-30 | $0.20B | $-0.02B | -11.56% |
2015-03-31 | $0.21B | $-0.01B | -6.67% |
2014-12-31 | $0.23B | $-0.01B | -3.90% |
2014-09-30 | $0.29B | $-0.01B | -3.51% |
2014-06-30 | $0.27B | $-0.02B | -8.86% |
2014-03-31 | $0.26B | $-0.03B | -9.65% |
2013-12-31 | $0.25B | $-0.03B | -11.74% |
2013-09-30 | $0.24B | $-0.04B | -14.83% |
2013-06-30 | $0.23B | $-0.03B | -11.30% |
2013-03-31 | $0.22B | $-0.03B | -14.03% |
2012-12-31 | $0.21B | $-0.04B | -16.98% |
2012-09-30 | $0.20B | $-0.04B | -20.40% |
2012-06-30 | $0.19B | $-0.04B | -22.51% |
2012-03-31 | $0.17B | $-0.05B | -27.33% |
2011-12-31 | $0.15B | $-0.04B | -28.29% |
2011-09-30 | $0.13B | $-0.04B | -31.58% |
2011-06-30 | $0.11B | $-0.04B | -35.40% |
2011-03-31 | $0.10B | $-0.04B | -33.65% |
2010-12-31 | $0.10B | $-0.04B | -40.21% |
2010-09-30 | $0.09B | $-0.04B | -46.07% |
2010-06-30 | $0.08B | $-0.05B | -55.42% |
2010-03-31 | $0.08B | $-0.05B | -69.33% |
2009-12-31 | $0.07B | $-0.06B | -87.88% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $20.168B | $2.072B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $218.593B | 25.64 |
Boston Scientific (BSX) | United States | $157.132B | 37.53 |
Stryker (SYK) | United States | $151.401B | 31.66 |
EssilorLuxottica (ESLOY) | France | $135.007B | 0.00 |
Medtronic (MDT) | Ireland | $118.404B | 16.78 |
Lonza Group Ag (LZAGY) | Switzerland | $49.975B | 0.00 |
Haleon (HLN) | United Kingdom | $44.249B | 25.26 |
ResMed (RMD) | United States | $40.103B | 30.12 |
GE HealthCare Technologies (GEHC) | United States | $35.152B | 16.69 |
Agilent Technologies (A) | United States | $34.187B | 22.29 |
Terumo (TRUMY) | Japan | $25.999B | 33.77 |
Koninklijke Philips (PHG) | Netherlands | $24.882B | 17.46 |
Zimmer Biomet Holdings (ZBH) | United States | $19.166B | 12.31 |
Baxter (BAX) | United States | $14.764B | 11.02 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.788B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.131B | 24.82 |
Lantheus Holdings (LNTH) | United States | $4.907B | 12.38 |
Perrigo (PRGO) | Ireland | $3.864B | 9.79 |
Prestige Consumer Healthcare (PBH) | United States | $3.769B | 16.84 |
Haemonetics (HAE) | United States | $3.568B | 16.25 |
Envista Holdings (NVST) | United States | $3.503B | 29.11 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.180B | 23.45 |
LeMaitre Vascular (LMAT) | United States | $1.825B | 40.79 |
QuidelOrtho (QDEL) | United States | $1.781B | 12.25 |
AtriCure (ATRC) | United States | $1.494B | 0.00 |
Acuren (TIC) | United States | $1.450B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.268B | 28.52 |
AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
Phibro Animal Health (PAHC) | United States | $1.193B | 15.25 |
Neogen (NEOG) | United States | $1.111B | 14.22 |
BioLife Solutions (BLFS) | United States | $1.065B | 0.00 |
InMode (INMD) | Israel | $0.918B | 9.25 |
Kestra Medical Technologies (KMTS) | United States | $0.871B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.851B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.707B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.690B | 0.00 |
Valneva SE (VALN) | France | $0.646B | 0.00 |
Evolus (EOLS) | United States | $0.622B | 0.00 |
Owens & Minor (OMI) | United States | $0.613B | 5.09 |
CeriBell (CBLL) | United States | $0.556B | 0.00 |
ZimVie (ZIMV) | United States | $0.522B | 23.71 |
Surmodics (SRDX) | United States | $0.458B | 0.00 |
SNDL (SNDL) | Canada | $0.405B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.311B | 11.44 |
Cresco Labs (CRLBF) | United States | $0.311B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
Quanterix (QTRX) | United States | $0.275B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.271B | 80.17 |
Cerus (CERS) | United States | $0.260B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.249B | 20.97 |
OraSure Technologies (OSUR) | United States | $0.248B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.228B | 0.00 |
Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
Biote (BTMD) | United States | $0.228B | 6.40 |
Brainsway (BWAY) | Israel | $0.224B | 59.20 |
Omeros (OMER) | United States | $0.210B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.203B | 0.00 |
Organigram Global (OGI) | Canada | $0.202B | 0.00 |
High Tide (HITI) | Canada | $0.192B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.189B | 15.52 |
TriSalus Life Sciences (TLSI) | United States | $0.177B | 0.00 |
Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
Exagen (XGN) | United States | $0.154B | 0.00 |
FitLife Brands (FTLF) | United States | $0.125B | 15.34 |
TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
MacroGenics (MGNX) | United States | $0.112B | 0.00 |
Jin Medical (ZJYL) | China | $0.104B | 0.00 |
Fonar (FONR) | United States | $0.098B | 12.70 |
Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Apyx Medical (APYX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.088B | 0.00 |
Safety Shot (SHOT) | United States | $0.085B | 0.00 |
Zynex (ZYXI) | United States | $0.077B | 0.00 |
InterCure (INCR) | Israel | $0.070B | 0.00 |
Agape ATP (ATPC) | $0.069B | 0.00 | |
Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.061B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 14.92 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
Nephros (NEPH) | United States | $0.036B | 49.14 |
Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Senestech (SNES) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |